Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom van der Poll

Showing results (61-70 of 774) with videos related to

Pageof 78
Sort By:
Best Practice & Research. Clinical Haematology|December 27, 2005
Plasma and plasma components in the management of disseminated intravascular coagulationMarcel Levi, Evert de Jonge, Tom van der Poll
Critical Care (London, England)|February 8, 2008
Targeting RAGE in sepsisMarieke A D van Zoelen, Tom van der Poll
Circulation|June 9, 2004
Bidirectional relation between inflammation and coagulationMarcel Levi, Tom van der Poll, Harry R Büller
Journal of Thrombosis and Thrombolysis|February 5, 2004
Sepsis and disseminated intravascular coagulationMarcel Levi, Evert de Jonge, Tom van der Poll
Seminars in Thrombosis and Hemostasis|February 16, 2006
Tissue factor in infection and severe inflammationMarcel Levi, Tom van der Poll, Hugo ten Cate
Annals of Translational Medicine|February 12, 2019
Initiation of renal replacement therapy in patients with sepsis: more to it than meets the eyeFabrice Uhel, Hessel Peters-Sengers, Tom van der Poll
Current Drug Targets|April 18, 2003
Anticoagulant therapy for acute lung injury or pneumoniaMarcus J Schultz, Marcel Levi, Tom van der Poll
Annals of Medicine|March 6, 2004
New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiologyMarcel Levi, Evert de Jonge, Tom van der Poll
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-gamma response to lipopolysaccharide and staphylococcal enterotoxin BRosemarijn Renckens, Jennie M Pater, Tom van der Poll
Annual Review of Physiology|October 27, 2021
Sepsis-Induced ImmunosuppressionLisa K Torres, Peter Pickkers, Tom van der Poll
Pageof 78

Showing results (61-70 of 774) with videos related to

Sort By:
Pageof 78
Best Practice & Research. Clinical Haematology|December 27, 2005
Plasma and plasma components in the management of disseminated intravascular coagulationMarcel Levi, Evert de Jonge, Tom van der Poll
Critical Care (London, England)|February 8, 2008
Targeting RAGE in sepsisMarieke A D van Zoelen, Tom van der Poll
Circulation|June 9, 2004
Bidirectional relation between inflammation and coagulationMarcel Levi, Tom van der Poll, Harry R Büller
Journal of Thrombosis and Thrombolysis|February 5, 2004
Sepsis and disseminated intravascular coagulationMarcel Levi, Evert de Jonge, Tom van der Poll
Seminars in Thrombosis and Hemostasis|February 16, 2006
Tissue factor in infection and severe inflammationMarcel Levi, Tom van der Poll, Hugo ten Cate
Annals of Translational Medicine|February 12, 2019
Initiation of renal replacement therapy in patients with sepsis: more to it than meets the eyeFabrice Uhel, Hessel Peters-Sengers, Tom van der Poll
Current Drug Targets|April 18, 2003
Anticoagulant therapy for acute lung injury or pneumoniaMarcus J Schultz, Marcel Levi, Tom van der Poll
Annals of Medicine|March 6, 2004
New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiologyMarcel Levi, Evert de Jonge, Tom van der Poll
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Plasminogen activator inhibitor type-1-deficient mice have an enhanced IFN-gamma response to lipopolysaccharide and staphylococcal enterotoxin BRosemarijn Renckens, Jennie M Pater, Tom van der Poll
Annual Review of Physiology|October 27, 2021
Sepsis-Induced ImmunosuppressionLisa K Torres, Peter Pickkers, Tom van der Poll
Pageof 78